Results 201 to 210 of about 14,643 (342)

Urothelial carcinoma: Perioperative considerations from top to bottom

CA: A Cancer Journal for Clinicians, EarlyView.
Abstract Urothelial carcinoma is an aggressive entity that is associated with significant morbidity, but there have been major advances in both our understanding of and treatment options for patients with this disease. In this review, the authors focus on novel therapeutic and diagnostic approaches in the perioperative setting, with an emphasis on ...
Wesley Yip, Salvador Jaime‐Casas, Anjaney Kothari, Mary Sullivan, Leslie K. Ballas, Domenique Escobar, Anne K. Schuckman, Jonathan E. Rosenberg, Jonathan A. Coleman   +8 more
wiley   +1 more source

The impact of concomitant therapies on the efficacy and safety of relugolix in advanced prostate cancer. [PDF]

Future Oncol
Shore ND, George DJ, Spratt DE, De La Cerda J.   +3 more
europepmc   +1 more source

The contemporary management of prostate cancer

CA: A Cancer Journal for Clinicians, EarlyView.
Abstract Prostate cancer is the most common cancer in two thirds of the world, with an expected doubling in both incidence and mortality in the next two decades. No strong environmental associations exist for the development of prostate cancer; therefore, lifestyle measures are unlikely to mitigate this increasing burden.
Deep Chakrabarti, Peter Albertsen, Aidan Adkins, Amar Kishan, Vedang Murthy, Chris Parker, Angela Pathmanathan, Alison Reid, Oliver Sartor, Nicholas Van As, Jochen Walz, Alison Tree   +11 more
wiley   +1 more source

Relationship Between Loss of Y Chromosome and Urologic Cancers: New Future Perspectives. [PDF]

Cancers (Basel)
Russo P, Bizzarri FP, Filomena GB, Marino F, Iacovelli R, Ciccarese C, Boccuto L, Ragonese M, Gavi F, Rossi F, Savoia C, Suraci PP, Falabella R, Pandolfo SD, Napolitano L, Leoni C, Trevisan V, Palermo G, Racioppi M, Sacco E, Muselaers S, Foschi N.   +21 more
europepmc   +1 more source

Importance of continuous monitoring of bovine leukaemia virus infection on farms in bovine leukaemia virus‐endemic areas of Japan

Veterinary Record Open, Volume 12, Issue 2, December 2025.
Abstract Background Enzootic bovine leukosis (EBL), caused by the bovine leukaemia virus (BLV), has exhibited increasing infection rates in Japan. While many farms implement various infection prevention measures, practical challenges—such as barn structure and availability of replacement cattle—can hinder farm purification efforts.
Chikako Tani, Jiazhou Li, Hirohisa Mekata, Kazuhiro Morishita, Shingo Nakahata   +4 more
wiley   +1 more source

Circulating levels of cytokines and risk of urologic cancers: a two-sample Mendelian randomization study. [PDF]

BMC Cancer
Song J, Sun X, Wang T, Li C, Yuan L.
europepmc   +1 more source

Surgical management for upper urinary tract transitional cell carcinoma [PDF]

, 2011
Biyani, Chandra S., Coles, Bernadette, El-Mokadem, Ismail, Nabi, Ghulam, Rai, Bhavan Prasad, Shelley, Mike   +5 more
core   +2 more sources

Identification and Evaluation of the Urinary Microbiota Associated With Bladder Cancer

Cancer Innovation, Volume 4, Issue 4, August 2025.
Urinary microbiota in Chinese bladder cancer patients reveals distinct profiles between non‐muscle‐invasive and muscle‐invasive diseases, with potential biomarkers like Peptoniphilus spp. in high‐risk MIBC, suggesting a role in cancer progression. Dysbiosis may serve as a stratification marker for bladder cancer risk. ABSTRACT Background Bladder cancer
Nannan Li, Lei Wang, Qin Yang, Fuqiang Li, Zhun Shi, Xiujie Feng, Liwei Zhang, Xiaojian Li, Xin Jin, Shida Zhu, Kui Wu, Ningchen Li   +11 more
wiley   +1 more source

Malignancy in Systemic Sclerosis: A Multicenter Retrospective Study. [PDF]

Biomedicines
Nemes-Tömöri D, Jász DK, Tari D, Bói B, Ágoston-Szabó Á, Szűcs G, Majai GE.   +6 more
europepmc   +1 more source

BRCA Mutation Testing in Men With Metastatic Castration‐Resistant Prostate Cancer: Practical Guidance for Australian Clinical Practice

Asia-Pacific Journal of Clinical Oncology, Volume 21, Issue 4, Page 345-358, August 2025.
Molecular diagnostic testing identified mCRPC patients with BRCA mutations eligible for targeted therapies. Testing success is often contingent on the quality of tissue handling and laboratory processing techniques to minimize DNA degradation and suboptimal sequencing data quality.
Arun A. Azad, Howard Gurney, Ainsley Campbell, Jeffrey C. Goh, Vivek Rathi   +4 more
wiley   +1 more source